Sonora Quest Laboratories is using A.I. for risk assessment and prevention
By William Tsun
Most physicians can assess whether a patient is developing Alzheimer’s disease in five minutes, according to the Alzheimer’s Association. But few general practitioners include the screening in checkups, even though it’s covered as a yearly Medicare benefit.
“Honestly, most doctors don’t want to find it,” says Tom Leggett, director of business development for Sonora Quest Laboratories in Tempe. “The uncomfortable truth is when you’re a physician and you find moderate or severe Alzheimer’s in your patient, it’s not a happy conversation. Because there’s nothing you can do about it – or at least, in the past, that was the thinking.”
Leggett hopes Sonora Quest can change that with advanced artificial intelligence technology developed with Raleigh, North Carolina’s uMETHOD Health. Its RestoreU aims to interpret data from a patient’s medical history, biospecimens and even demographics to develop individualized plans that can help doctors manage the incurable degenerative brain disease – or at least slow its progress.
To read the full article, click here.